The Deloitte Technology Fast 500 aims to be one of the most objective rankings for technology, media, telecommunications, life sciences, and energy technology firms for the past 25 years. As noted on the Big Four auditing firm’s website: “Combining technological innovation, entrepreneurship, and rapid growth,… Read More
Pharma giant Pfizer has reportedly become one of the latest companies to join the MediLedger Project, which is a blockchain protocol program for supply chain management. McKesson Corporation, AmerisourceBergen Corporation, and Primer Inc. have also joined the program. The MediLedger Project is described as a… Read More
Earlier this week, IBM (NYSE: IBM) and Sichuan Hejia Co., Ltd. (Hejia) announced they have collaborated to launch a new blockchain-based supply chain financial service platform specifically for pharmaceutical procurement. The companies confirmed that the new service is to help improve efficiency, transparency, and operation of… Read More
Liverpool ChiroChem, a pharmaceutical research and biotechnology company, has launched a crowdfunding initiative on SyndicateRoom to raise £550,000 for expansion and a new manufacturing process. According to Insider Media, the company was founded in 2014 and has developed a manufacturing process to make pure chemicals in three… Read More
A surprising chain of related facts: Gila monster lizards have poisonous saliva. A drug derived from it, Exenatide, acts like a natural hormone, helping diabetes patients produce their own insulin. And Venomtech is the first UK company to sell venoms in a form tailored for use by drug discovery companies, so that they… Read More
Crowdfund Insider is the leading news and information web site covering the emerging global industry of disruptive finance including investment crowdfunding, Blockchain peer-to-peer / marketplace lending and other forms of Fintech.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it and agree to our terms of service.Ok